Subject: Opioids

Drug User Health in a Syndemic Environment

This session addresses challenges related to living and accessing services in a syndemic environment. It covers those strategies that ensure individuals are able to address co-morbidities.

All four 2023 Harm Reduction Conference training sessions must be taken to receive a total of 3.25 credit hours.

Social Justice/Language Justice

This plenary focuses on how to eliminate and replace stigmatizing language and negative bias while also using person-first language within communities of people who struggle with substance use disorder to increase access to services and successful retention in care.

All four 2023 Harm Reduction Conference training sessions must be taken to receive a total of 3.25 credit hours.

National Perspectives on Harm Reduction and Community Health

This session describes the impact of drug use from a national and local perspective, examines the social impact of drug use on communities, and identifies national and local harm reduction activities. Surveillance data will be presented to highlight national and local trends.

All four 2023 Harm Reduction Conference training sessions must be taken to receive a total of 3.25 credit hours.

Destigmatization of Drug Use

This session explores the impact of stigma on people who have been diagnosed with substance use disorder (SUD) and those who are not clinically diagnosed but display symptoms. The presenter examines the relationship between stigma and systemic racism, as well as racism’s compounding effect on access to healthcare services for people who use drugs. The presenter also provides strategies for challenging stigma and misconceptions about SUD.

TIP 63: Medications for Opioid Use Disorder

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.

The Opioid Crisis and the Black/African American Population: An Urgent Issue

This issue brief presents recent data on prevalence of opioid misuse and death rates in the Black/AA population; contextual factors & challenges to prevention & treatment; innovative outreach & engagement strategies to connect people to evidence-based treatment; and the importance of community voice.

PCSS Resources for Health Professionals, Patients and Community

These resources for treating OUD and chronic pain were developed for health professionals, patients, family members and significant others of patients and the general community to learn more about the evidence-based treatment of opioid use disorders and the treatment of chronic pain.

Essentials of Opioid Use Disorder: A Resource for Hepatologists and Infectious Disease Specialists Managing HCV and/or HIV Infection

Download this PDF guide outlining key information on identifying and treating opioid use disorder among patients with HIV and or HCV infection.

Clinical Mentoring for Treating OUD

The overarching goal of PCSS is to provide the most effective evidence-based clinical practices in preventing OUD through proper opioid prescribing practices, identifying patients with OUD, and the treatment of opioid use disorder.

HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics

HHS’s guide on dosage reduction, tapering, or discontinuation of long-term opioid analgesics.